Clinical Trials Browser

Interventional × Lymphoma, Follicular × avelumab × Clear all

NCT03636503 2025-02-06

Rituximab + Immunotherapy in Follicular Lymphoma

Phase 1 Terminated

24 enrolled 25 charts

Lymphoma, Lymphoma, Follicular

NCT03147404 2019-12-30

MS100070-0177

Phase 2 Completed

EndocrineLymphoid

Lymphoma, Follicular, Carcinoma, Neuroendocrine